HbA1c Trajectory and Its Associated Factors in Patients with Type 2 Diabetes

被引：0
|
作者：
Yu, Tzu-Yun
Li, Tsai-Chung
Lin, Cheng-Chieh
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2425-PUB
引用
收藏
页码：A607 / A607
页数：1
相关论文
共 50 条
  • [1] Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitus
    Wu, Tzu-En
    Su, Yu-Wen
    Chen, Harn-Shen
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 192
  • [2] Metabolomics profiles associated with HbA1c levels in patients with type 2 diabetes
    Yun, Jun Ho
    Lee, Heun-Sik
    Yu, Ho-Yeong
    Kim, Yeon-Jung
    Jeon, Hyun Jeong
    Oh, Taekeun
    Kim, Bong-Jo
    Choi, Hyung Jin
    Kim, Jeong-Min
    PLOS ONE, 2019, 14 (11):
  • [3] Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors
    Kurukulasuriya, L. Romayne
    Sowers, James R.
    CARDIOVASCULAR DIABETOLOGY, 2010, 9
  • [4] Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors
    L Romayne Kurukulasuriya
    James R Sowers
    Cardiovascular Diabetology, 9
  • [5] Modelling HbA1c Trajectory in Patients with Type 2 Diabetes Mellitus (T2DM)
    Mcewan, Phil
    Fellows, Jonathan
    Yapp, Rhiannon
    Bergenheim, Klas
    Qin, Lei
    Varol, Nebibe
    Bennett, Hayley
    Gordon, Jason
    DIABETES, 2016, 65 : A322 - A322
  • [6] Longitudinal HbA1c trajectory modelling reveals the association of HbA1c and risk of hospitalization for heart failure for patients with type 2 diabetes mellitus
    Tee, Clarence
    Xu, Haiyan
    Fu, Xiuju
    Cui, Di
    Jafar, Tazeen H. H.
    Bee, Yong Mong
    PLOS ONE, 2023, 18 (01):
  • [7] Depressive symptoms and HbA1c in patients with Type 1 and Type 2 diabetes
    Kawada, T.
    DIABETIC MEDICINE, 2014, 31 (06) : 759 - 760
  • [8] Lowering of HbA1c in type 2 diabetes is not associated with progression of retinopathy
    Jovanovic, L
    DIABETES, 1999, 48 : A392 - A392
  • [9] FACTORS ASSOCIATED WITH AND IMPLICATIONS OF MEETING OR NOT MEETING HBA1C TARGETS IN TYPE 2 DIABETES MELLITUS
    Higgins, V
    Harrison, L.
    Sullivan, E.
    Piercy, J.
    VALUE IN HEALTH, 2019, 22 : S141 - S141
  • [10] Drug treatment of type 2 diabetes: Its cost is significantly associated with HbA1c levels
    Elgart, Jorge F.
    Silvestrini, Constanza
    Prestes, Mariana
    Gonzalez, Lorena
    Rucci, Enzo
    Gagliardino, Juan J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (04)
12345